P

Pfizer

Makes cancer drugs, vaccines and other medicines

US Field Medical Operational Excellence Director

Full-TimePosted on 10/19/2026Deadline 11/3/26
$176.6k - $294.3k/yr+ 20% target bonus + Share-based long-term incentive
Expert
Bachelor's, Master's, PharmD, PhD
Cambridge, MA, USA+5 moreMore locations: Collegeville, PA, USA | Lake Forest, IL, USA | Groton, CT, USA | New York, NY, USA | San Diego, CA, USA
HybridRequires working on-site 2 to 3 days per week.
Business & StrategyBusiness Operations
No H1B Sponsorship

About the job

Requirements
  • A bachelor's degree and at least 8 years of experience in the pharmaceutical industry or related fields; alternatively, an advanced degree such as a master's and at least 7 years of relevant experience, or a PharmD or PhD and at least 5 years of relevant experience.
  • Demonstrated hands-on use of artificial intelligence tools, data analysis, and process automation to solve business problems and improve operational efficiency.
  • Ability to influence and collaborate with peers, develop and coach others, and oversee and guide colleagues' work to achieve meaningful outcomes and business impact.
  • Strong project management and operational skills, including creating and managing complex projects, budgetary management, fiscal awareness, resource management, and management of multiple projects.
  • Understanding and adherence to project management methodologies.
  • Ability to collaborate across Medical, Medical Information, Corporate Communications, Digital, and Commercial functions, including customer-facing and headquarters teams.
  • Ability to lead effectively in a matrix organization and communicate and work with all levels of management.
  • Ability to facilitate stakeholder discussion and debate, build relationships through partnering, anticipate needs, and fulfill expectations.
  • Ability to independently manage priorities and multiple tasks with tight deadlines, using strong organizational, attention-to-detail, and follow-up skills.
  • Knowledge of Pfizer systems, including Portfolio on Demand, Ariba BOD, and EngagePlus.
  • Proficiency in Microsoft Excel, Word, PowerPoint, and Teams.
  • Working knowledge of Field Medical enablement platforms and processes, including CLM, One Med, and SharePoint.
  • Advanced, regular use of enterprise generative AI tools such as Claude; ability to design, test, and refine prompts and reusable prompt templates, build AI-assisted workflows, and coach colleagues in effective, responsible, and compliant AI use, including data privacy and responsible AI considerations for HCP-facing tools and data in Medical Affairs.
  • Experience consolidating and cleansing data from multiple systems, applying analytical methods, and translating findings into insights and dashboards using tools such as Power BI and Excel.
  • Experience bridging end users, leadership, Digital, systems support teams, and vendors; translating business needs into requirements and managing priorities, trade-offs, and service expectations.
  • Experience delivering system implementations and enhancements end to end, including requirements, testing, deployment, and post-launch support.
  • Experience with structured change management, including stakeholder impact assessment, communications, training, and adoption measurement.
  • Strong decision-making, strategic thinking, business judgment, and resourcefulness in a rapidly changing environment.
  • Full knowledge and understanding of relevant applicable standard operating procedures.
  • Proven ability to implement strategically important projects on time and within budget.
  • Ability to manage projects with team members in multiple locations and influence without authority.
  • Fluency in spoken and written English and ability to influence others.
  • Flexibility and ability to adapt to changes in the external environment, project scope, and direction.
  • Ability to travel 20% of the time, including potential international travel.
  • Must be authorized to work in the United States by any employer and have permanent work authorization in the United States.
Responsibilities
  • Support the Specialty Care Field Medical Director Lead in aligning and coordinating goals, priorities, and efforts across Medical Affairs categories, asset teams, and cross-functional partners.
  • Contribute as a thought partner to assigned Field Medical Affairs leads and teams in developing future-facing vision, mission, and strategic initiatives.
  • Support assigned Field Medical Affairs leads in coordinating goals, priorities, and efforts across Medical Affairs categories, asset teams, and cross-functional partners.
  • Support implementation of organizational and team-specific Medical Affairs change management plans in collaboration with change management team members.
  • Identify, share, and implement best practices; promote consistency in overarching processes and systems; and develop partnerships across functions to maintain alignment and efficiency.
  • Develop and maintain business relationships with Finance, Contracts and Outsourcing, Compliance, and Operational Excellence colleagues to advance Medical Affairs projects.
  • Drive creation and implementation of medical processes and standard operating procedures with stakeholders to support Medical Affairs strategy and execution of data generation and communication activities.
  • Coordinate with Operational Excellence team members across categories to standardize approaches, processes, and standard operating procedures.
  • Support asset-specific governance committees to advance effective decision-making.
  • Support assigned Medical Affairs activities and initiatives, including developing and monitoring project and program plans and tracking milestones.
  • Drive agendas and facilitate Field Medical Team meetings, ensuring minutes are recorded and filed.
  • Provide presentation-development support for internal meetings.
  • Develop and lead tracking of performance and activity metrics, and share and coordinate those measures with the Medical Impact and Outcomes team.
  • Collaborate and align with internal stakeholders and Operational Excellence colleagues to maintain consistency.
  • Serve as the US Field Medical Governance and Compliance Lead for customer-facing medical teams within US Specialty Care Field Medical; liaise with Legal, Compliance, and Governance on processes and issues and support ongoing training and understanding across US Field teams.
  • Support financial management and forecasting with limited oversight for assigned asset or Field Medical area budgets, working with Finance, Field Medical leads, and team members.
  • Partner with Legal, Procurement, Finance, and external customers to develop and execute consultant agreements, service-level agreements, program schedules, and Confidential Disclosure Agreements; lead project-management financial activities to ensure timely and compliant invoice routing and approval.
  • Support project and program budget plans for assigned assets or Field Medical groups and provide management with accurate year-to-date spending information.
  • Provide financial guidance and serve as a resource for questions.
  • Collaborate with Medical, Finance, and Financial Systems teams, including Portfolio on Demand and OnTrack teams, to ensure accurate forecasting and budget management.
  • Support development of the Field Medical Strategic and Operating Plan and the Operating Plan process for the assigned Field Medical area.
  • Own day-to-day operations of Field Medical enablement platforms and serve as the primary operational contact and subject matter expert for core systems, including CLM, One Med, and SharePoint; partner with Digital, Customer Engagement Systems, Field Medical Excellence teams, and vendors on configuration, enhancements, releases, user access, and field-device readiness.
  • Lead rollout of new and enhanced enablement capabilities, including AI-enabled tools, from requirements gathering and user acceptance testing through deployment, training, job aids, communications, and adoption tracking.
  • Identify workflow pain points and apply AI, automation, low-code solutions, and data analysis to simplify processes; build reports and dashboards to measure system usage, adoption, and impact; and manage related projects with plans, milestones, and stakeholder communications.
Desired Qualifications
  • Operational experience or experience supporting medical organizations.
  • Prior experience working in a Medical Affairs organization and experience in other medical or clinical functions.
  • Prior experience in project management and business operations.
  • Expertise or experience in Specialty Care Field Medical.
  • Highly motivated, with a demonstrated track record of high performance and producing results.
  • Role-model Pfizer's values of Courage, Excellence, Equity, and Joy.

About the company

Pfizer discovers, makes, and sells prescription medicines and vaccines for patients, doctors, and governments worldwide, with large businesses in vaccines, cancer, heart disease, and rare diseases. In 2020, its COVID-19 shot, developed with German partner BioNTech, became the first COVID-19 vaccine authorized in the United States. Its scientists find drug candidates and run clinical trials to prove they are safe and effective, and Pfizer then manufactures approved products in its own plants, earning most of its money from patented drugs before cheaper generic copies arrive. Pfizer was founded in 1849 as a chemicals business in Brooklyn and is based in New York City.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Get referred to Pfizer

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Newer drugs carry the business: launched and acquired products grew 18% operationally in Pfizer's August 2026 quarterly report.
  • The outlook improved: in August 2026, Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion.
  • Vaccine scientists get room to grow: Pfizer's $470 million Pearl River, New York research expansion is designed for 370 workers.

What critics are saying

  • Expect more site cuts: in November 2025, Pfizer moved to shrink Swiss staff from about 300 to roughly 70.
  • Generics will erase sales: Pfizer expects patent losses to cut $17 billion to $18 billion of yearly revenue through 2028.
  • Pfizer is chasing obesity leaders: Metsera's monthly shot showed 12.3% weight loss at 28 weeks in February 2026 data.

What makes Pfizer unique

  • Pfizer bought its way into cancer: its Seagen buyout added antibody-drug conjugates, which carry chemotherapy straight to tumors.
  • Pfizer is betting on monthly obesity shots: Metsera's berobenatide is dosed once a month, unlike weekly Wegovy and Zepbound.
  • Pfizer leans on one partnered heart drug: blood thinner Eliquis, sold with Bristol Myers Squibb, brings about 14% of revenue.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Hybrid Work Options
  • Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-3%

2 year growth

-3%
Yahoo Finance
Oct 19th, 2026
Five low-beta dividend stocks: Pfizer yields 5.83%, Coca-Cola raises payout since 1999

Five defensive dividend stocks offer income with less volatility than the broader market, according to a 24/7 Wall St. analysis. All five have a beta well below 1, meaning they have historically moved less than the market. Pfizer leads with a forward yield of 5.83% at $29.49 a share. AT&T yields 4.77% at $23.27, and its $1.11 dividend uses about 42% of 2026 free cash flow guidance of $18B+. Debt of $144B is its main risk. Dominion Energy yields 4.24%, while Coca-Cola and Colgate-Palmolive each yield 2.27%. Coca-Cola has raised its dividend every year since 1999, and Colgate's next ex-dividend date is October 20, 2026.

Yahoo Finance
Oct 15th, 2026
GSK beats Pfizer as dividend stock: 39% payout vs 89% of free cash flow

GSK looks the better dividend stock than Pfizer, according to a comparison of the two drugmakers, which both face major patent losses before 2030. Pfizer yields 6.3% and GSK 4.1%. Over the twelve months to June 2026, Pfizer paid out 89% of its free cash flow in dividends ($9.79 billion of $10.98 billion), against 39% at GSK (£2.67 billion of £6.90 billion). Pfizer's chief executive officer, Albert Bourla, said the dividend will be maintained even in "the most stretched scenarios." Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion. GSK raised its dividend 17.6% in fiscal 2025 after an earlier cut, and Q2 2026 sales rose 5%. Its main risk is debt: net debt rose to £22 billion after the Nuvalent acquisition.

Yahoo Finance
Oct 14th, 2026
Pfizer's 6% dividend pays investors to wait as oncology pipeline drives growth beyond COVID-19

Pfizer offers a dividend yield of just over 6% while it builds growth beyond its COVID-19 products. The drugmaker declared a quarterly dividend of $0.43 in June 2026, its 351st consecutive quarterly payment. In the second quarter, revenue from launched and acquired products rose 18% year over year. Pfizer raised the midpoint of its full-year guidance, helped by stronger non-COVID sales from drugs such as Eliquis, Padcev, and Vyndaqel. Oncology is the next focus. Pfizer is investing in antibody-drug conjugates and bispecific antibodies, and it entered a global collaboration with Innovent Biologics covering 12 early-stage cancer programs. Not every experimental drug will succeed, but a broader pipeline improves the odds. If new medicines work, the share price could rise on top of the dividend income.

Yahoo Finance
Oct 13th, 2026
Six high-yield dividend stocks fail the payout test, from Ford to Whirlpool's 9.37% mirage

High dividend yields can hide weak payouts, and a four-step test helps separate real income from traps. It checks earnings with one-offs stripped out, full-year free cash flow against dividends, management's explanation, and whether debt funds the gap. Ford yields 4.99% and shows a trailing EPS of -$1.88, caused by $4.2B in one-time charges. Its debt-to-equity of 4.66 leaves the $0.60 dividend exposed to a downturn. Pfizer yields 6.03%, but its free cash flow yield is 5.60%. Clorox's roughly $405M of free cash flow fell short of about $601M in dividends. Whirlpool fails every step. It cut its quarterly dividend from $1.75 to $0.90 in 2025, paid no common dividend in the second quarter of 2026, and its shares are down 59.48% since the end of 2025. 3M and Dow pass, with payouts now covered by cash.

Yahoo Finance
Oct 12th, 2026
UPS, Pfizer, Kraft Heinz and Ford dividends at risk as payouts outstrip earnings

Four blue chip companies, UPS, Pfizer, Kraft Heinz, and Ford, may struggle to sustain their dividends, according to an analysis of their earnings, cash flow, and debt. UPS yields 7.02% and pays out about 121% of its GAAP earnings. Pfizer yields 6.10%, with a GAAP payout ratio of about 226%; its 2025 free cash flow of $9.076 billion fell short of $9.771 billion in dividends. Kraft Heinz yields 6.82%, but its trailing GAAP earnings per share are −$2.88 after $7.4 billion in impairments. Ford yields 4.98% after an $8.162 billion loss in 2025, and its debt-to-equity ratio is 4.66. All four companies say their payouts are safe, and each points to adjusted earnings guidance that covers the dividend.